Cardiovascular efficacy of sitagliptin in patients with diabetes at high risk of cardiovascular disease: a 12-month follow-up
Crossref DOI link: https://doi.org/10.1186/s12933-016-0371-z
Published Online: 2016-03-31
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
,
Nakamura, Takashi
Iwanaga, Yoshitaka
Miyaji, Yuki
Nohara, Ryuji
Ishimura, Takao
Miyazaki, Shunichi
Funding for this research was provided by:
the Osaka Foundation for the Prevention of Cancer and Cardiovascular Disease (H23 No1)
